InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
16,900.80
(
-0.94%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
87.31
(
0.10%
)
Bitcoin
63,825.91
(
-0.71%
)
Post# of 251590
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119469
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 169165

Thursday, 11/14/2013 6:03:20 PM

Thursday, November 14, 2013 6:03:20 PM

Post# of 251590
The full detailed presentation of ABBV/ENTA’s six phase-3 HCV trials for the initial NDA (the first six trials listed in #msg-93647264) is planned for EASL in Apr 2014, according to ABBV’s CS webcast today. Top-line data from these trials will be released as the data become available, starting with SAPHIRE-1 and SAPHIRE-2 before 2013 year-end.

EASL 2014 webpage: http://www.easl.eu/_events/the-international-liver-congress/the-international-liver-congress-2014-49th-annual-meeting-of-the-european-association-for-the-study-of-the-liver .

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up